Tipranavir and cytolytic hepatitis Patient Reports February 11, 2012

Tipranavir Side Effects Report #5098984-4
Tipranavir side effect was reported by a Health Professional from FRANCE on Aug 31, 2006. Male patient, 55 years of age, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, dyspepsia, gamma-glutamyltransferase increased, hepatomegaly. Tipranavir dosage: unknown. During the same period patient was treated with NORVIR, DIDANOSINE, ENFUVIRTIDE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5113047-7
Tipranavir side effect was reported by a Health Professional from FRANCE on Aug 31, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatomegaly. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with VIDEX, FUZEON. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5359336-2
Tipranavir side effect was reported by a Consumer or non-health professional from on May 20, 2007. Male patient, weighting 158.7 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis. Tipranavir dosage: TIPRANAVIR/NORVIR: STRENGTH 250MG/100MG; DAILY DOSE: 1000MG/400MG. During the same period patient was treated with VIDEX, ZIAGEN, BISEPTOL, ESSENTIALETE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5367909-6
Tipranavir side effect was reported by a Consumer or non-health professional from on May 20, 2007. Male patient, weighting 158.7 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis. Tipranavir dosage: TIPRANAVIR/NORVIR: STRENGTH 250MG/100MG; DAILY DOSE: 1000MG/400MG. During the same period patient was treated with VIDEX, ZIAGEN, BISEPTOL, ESSENTIALETE. Patient was hospitalized. Patient recovered.


Tipranavir Side Effects Report #5160508-0
Tipranavir side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, weighting 172.0 lb, was diagnosed with hiv infection , prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cytolytic hepatitis. Tipranavir dosage: TPV/RTV: 500/200 MG B.I.D.. During the same period patient was treated with LEDERFOLIN, PYRIMETHAMINE, DAPSONE, VIREAD, SUSTIVA, FUZEON. Patient recovered.

Tipranavir Side Effects Report #5513599-9
Tipranavir side effect was reported by a Consumer or non-health professional from on Nov 05, 2007. Male patient, weighting 158.7 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis. Tipranavir dosage: TIPRANAVIR/NORVIR: STRENGTH 250MG/100MG; DAILY DOSE: 1000MG/400MG. During the same period patient was treated with VIDEX, ZIAGEN, BISEPTOL, ESSENTIALETE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4709951-1
Tipranavir side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, weighting 172.0 lb, was diagnosed with hiv infection , prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cytolytic hepatitis. Tipranavir dosage: TPV/RTV: 500/200 MG B.I.D.. During the same period patient was treated with LEDERFOLIN, MALOCIDE, DAPSONE, VIREAD, SUSTIVA, FUZEON. Patient recovered.

Tipranavir Side Effects Report #4727524-1
Tipranavir side effect was reported by a Consumer or non-health professional from FRANCE on June 07, 2004. Female patient, weighting 183.0 lb, was diagnosed with hiv infection , infection prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, BACTRIM. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4758452-3
Tipranavir side effect was reported by a Consumer or non-health professional from FRANCE on June 07, 2004. Female patient, weighting 183.0 lb, was diagnosed with hiv infection , infection prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, BACTRIM. Patient was hospitalized. Patient recovered.


Tipranavir Side Effects Report #4763490-0
Tipranavir side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, weighting 172.0 lb, was diagnosed with hiv infection , prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cytolytic hepatitis. Tipranavir dosage: TPV/RTV: 500/200 MG B.I.D.. During the same period patient was treated with LEDERFOLIN, MALOCIDE, DAPSONE, VIREAD, SUSTIVA, FUZEON. Patient recovered.

Tipranavir Side Effects Report #4808222-2
Tipranavir side effect was reported by a Consumer or non-health professional from on Jan 26, 2005. Female patient, weighting 154.3 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cough, cytolytic hepatitis, depression , diarrhoea, nausea , oesophageal candidiasis, pulmonary embolism , pyrexia. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, TRIZIVIR, COMBIVIR, VIREAD. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4808223-4
Tipranavir side effect was reported by a Consumer or non-health professional from FRANCE on June 07, 2004. Female patient, weighting 183.0 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, BACTRIM. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4846548-7
Tipranavir side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, weighting 172.0 lb, was diagnosed with hiv infection , prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cytolytic hepatitis. Tipranavir dosage: TPV/RTV: 500/200 MG B.I.D.. During the same period patient was treated with LEDERFOLIN, MALOCIDE, DAPSONE, VIREAD, SUSTIVA, FUZEON. Patient recovered.

Tipranavir Side Effects Report #4913588-9
Tipranavir side effect was reported by a Consumer or non-health professional from FRANCE on June 07, 2004. Female patient, weighting 165.3 lb, was diagnosed with hiv infection , antibiotic prophylaxis and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic steatosis. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, BACTRIM. Patient was hospitalized. Patient recovered.


Tipranavir Side Effects Report #4930848-6
Tipranavir side effect was reported by a Consumer or non-health professional from on Jan 26, 2005. Female patient, weighting 154.3 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: cholestasis, cough, cytolytic hepatitis, depression , diarrhoea, nausea , oesophageal candidiasis, pulmonary embolism . Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with FUZEON, TRIZIVIR, COMBIVIR, VIREAD. Patient was hospitalized. Patient recovered.